Cartagena and the North-South Divide over GMOs

By Gebre Egziabher, Tewolde Berhan | Contemporary Review, January 2004 | Go to article overview

Cartagena and the North-South Divide over GMOs

Gebre Egziabher, Tewolde Berhan, Contemporary Review

AS THE world's attention was focussed firmly on the Cancun World Trade Organisation summit last September 2003, an important international agreement quietly made its entry on the world stage, holding out immense implications for developing countries. The Cartagena Protocol on Bio-Safety, which aims to regulate trade in genetically modified organisms (GMOs), came into force on 11 September after five-year-long negotiations over trade advantages and disadvantages--intractable North-South issues that are set to continue to bedevil the Protocol's implementation.

This is highlighted most forcefully by the US move to take the European Union to the WTO dispute settlement mechanism over the EU's insistence that US exporters clearly label all GM food sold to Europe. One of America's main complaints is that Europe's stand makes Africa reject GM. The elephants that are Europe and the US thus fight, and the grass that is Africa gets trampled. The WTO Ministerial Meeting in Cancun, Mexico, which would have had direct or indirect implications on the case, collapsed on 14 September 2003, largely because the South, and especially Africa, refused to accommodate the elephants.

Is this a foretaste of the future of the implementation of the Bio-Safety Protocol as well? Why do I foresee future difficulties? The reasons are many, flowing chiefly from the substantive differences between the developing countries and the US over GMO regulation. The US, which is unlikely to be a party to the Protocol, and the sixty parties to the Protocol start from opposing premises. The US starts from the premise of 'Substantial Equivalence', which says GM crops are as safe as non-GM ones unless proved otherwise. The EU and the developing world support the 'Precautionary Principle' embodied in the Protocol which states that a GM crop is to be considered possibly risky unless proved to be safe. From these perceived differences flow implications for implementation.

The Cartagena Protocol requires a country to allow the importation of a GMO only after it has obtained all the necessary information about it and carried out a risk assessment to evaluate the likelihood of harm to human health, to agricultural systems, to its environment and to its socio-economic conditions. The country of import is first informed by the exporter or by the country of export of the intention to export the GMO. The country of import, after a risk assessment, then informs the exporter in writing whether or not it will allow the import.

In the case of GM commodities intended for food, feed or for processing, the intention to export is notified to all countries in one go through a computerised database system called the clearing-house. In this procedure, failure to communicate a decision to the country of export or to the clearing-house cannot be taken as an agreement to import. The failure might happen through lack of capacity and the Precautionary Principle would then imply that no exportation takes place. There are some exceptions to the procedure. A GMO that is merely transiting through a country is not subjected to the procedure. However, if a country considers any GMO as too dangerous to be allowed even transit, it has the right to register this fact at the clearing-house and prohibit its transiting. A GMO that is destined for contained use--under conditions from which it cannot escape into the open environment and cannot come into contact with humans or other forms of life--need not go through the procedure before importation. A GMO for use as a pharmaceutical for humans is subjected to the procedure unless there is another international law or a specified international organisation to govern its import and export authorisation. At the moment, there is no international law other than the Cartagena Protocol to govern the environmental impacts of GMOs. The World Health Organisation is responsible only for the safety to human health of pharmaceuticals--GMOs or otherwise--and not for their environmental impact. …

The rest of this article is only available to active members of Questia

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Default project is now your active project.
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Cite this article

Cited article

Citations are available only to our active members.
Buy instant access to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25,

Note: primary sources have slightly different requirements for citation. Please see these guidelines for more information.

Cited article

Cartagena and the North-South Divide over GMOs


Text size Smaller Larger Reset View mode
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Full screen

matching results for page

    Questia reader help

    How to highlight and cite specific passages

    1. Click or tap the first word you want to select.
    2. Click or tap the last word you want to select, and you’ll see everything in between get selected.
    3. You’ll then get a menu of options like creating a highlight or a citation from that passage of text.

    OK, got it!

    Cited passage

    Citations are available only to our active members.
    Buy instant access to cite pages or passages in MLA, APA and Chicago citation styles.

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

    1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25,

    New feature

    It is estimated that 1 in 10 people have dyslexia, and in an effort to make Questia easier to use for those people, we have added a new choice of font to the Reader. That font is called OpenDyslexic, and has been designed to help with some of the symptoms of dyslexia. For more information on this font, please visit

    To use OpenDyslexic, choose it from the Typeface list in Font settings.

    OK, got it!

    Cited passage

    Thanks for trying Questia!

    Please continue trying out our research tools, but please note, full functionality is available only to our active members.

    Your work will be lost once you leave this Web page.

    Buy instant access to save your work.

    Already a member? Log in now.

    Author Advanced search


    An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.